Physician profile
Bailey E Chitwood
NPI 1912544669
$22,148.88
in general payments reported to CMS, 2019-2025
30 companies · $4,160 in 2025
The $4,160 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,191 · 2022: $6,053 · 2023: $3,057 · 2024: $3,688 · 2025: $4,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,328.81 |
| Education | $575.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,689.13 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $2,709.89 | 2021-2025 | Ilumya, Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $1,979.52 | 2021-2025 | |
| Janssen Biotech, INC. | $1,605.78 | 2021-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $1,436.26 | 2021-2025 | Sotyktu |
| Incyte Corporation | $1,347.88 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $1,338.07 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $1,269.92 | 2021-2025 | |
| Leo Pharma INC. | $1,213.91 | 2021-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $1,097.06 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $876.13 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $590.23 | 2021-2025 | |
| Amgen INC. | $409.52 | 2021-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $351.16 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $350.54 | 2021-2025 | Nemluvio, Aklief |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $348.69 | 2021-2025 | |
| Vyne Pharmaceuticals INC. | $330.89 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $289.53 | 2021-2025 | Targretin, Jublia, Cabtreo |
| Janssen Scientific Affairs, LLC | $210.15 | 2022 | |
| Dermavant Sciences, INC. | $198.62 | 2022-2024 | Vtama |
| Regeneron Pharmaceuticals, INC. | $162.31 | 2021-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $99.99 | 2024 | |
| Mallinckrodt Hospital Products INC. | $37.98 | 2024 | Acthar |
| Verrica Pharmaceuticals INC. | $37.96 | 2024 | Ycanth |
| Organon LLC | $31.09 | 2023-2025 | Hadlima, Vtama |
| Mayne Pharma Commercial LLC | $30.89 | 2025 | |
| Ani Pharmaceuticals, INC. | $29.50 | 2025 | Purified Cortrophin Gel |
| Kyowa Kirin, INC. | $27.83 | 2023 | Poteligeo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.69 | 2022 | |
| Epi Health, LLC | $22.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Chitwood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.